Poulter, Neil

Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus

Hillis, G. S., Woodward, M., Rodgers, A., Chow, C. K., Li, Q., Zoungas, S., Patel, A., Webster, R., Batty, G. D., Ninomiya, T., et al. (2012) · Diabetologia

Heart rate and cardiovascular healthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 117

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

Östergren, J., Poulter, N. R., Sever, P. S., Dahlöf, B., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., et al. (2008) · Journal of Hypertension

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 116

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes

Mohammedi, K., Woodward, M., Marre, M., Colagiuri, S., Cooper, M., Harrap, S., Mancia, G., Poulter, N., Williams, B., Zoungas, S., et al. (2017) · Cardiovascular Diabetology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 111

Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial

Verma, S., Bhatt, D. L., Bain, S. C., Buse, J. B., Mann, J. F. E., Marso, S. P., Nauck, M. A., Poulter, N. R., Pratley, R. E., Zinman, B., et al. (2018) · Circulation

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 105

The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus

Blomster, J. I., Chow, C. K., Zoungas, S., Woodward, M., Patel, A., Poulter, N. R., Marre, M., Harrap, S., Chalmers, J., & Hillis, G. S. (2013) · Diabetes, Obesity and Metabolism

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 86

The impact of frailty on the effectiveness and safety of intensive glucose control and blood pressure-lowering therapy for people with type 2 diabetes: results from the ADVANCE trial

Nguyen, T. N., Harris, K., Woodward, M., Chalmers, J., Cooper, M., Hamet, P., Harrap, S., Heller, S., MacMahon, S., Mancia, G., et al. (2021) · Diabetes Care

Diabetes Treatment and ManagementFrailty in Older Adults

Cited by 72

Oral semaglutide and cardiovascular outcomes in people with type 2 diabetes, according to SGLT2i use: prespecified analyses of the SOUL randomized trial

Marx, N., Deanfield, J. E., Mann, J. F. E., Arechavaleta, R., Bain, S. C., Bajaj, H. S., Bayer Tanggaard, K., Birkenfeld, A. L., Buse, J. B., Davicevic-Elez, Z., et al. (2025) · Circulation

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 70

Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials

Lee, M. M. Y., Sattar, N., Pop-Busui, R., Deanfield, J., Emerson, S. S., Inzucchi, S. E., Mann, J. F. E., Marx, N., Mulvagh, S. L., Poulter, N. R., et al. (2025) · Diabetes Care

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 63

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial

Ohkuma, T., Jun, M., Rodgers, A., Cooper, M. E., Glasziou, P., Hamet, P., Harrap, S., Mancia, G., Marre, M., Neal, B., et al. (2019) · Hypertension

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 56

Safety of liraglutide in type 2 diabetes and chronic kidney disease

Mann, J. F. E., Fonseca, V. A., Poulter, N. R., Raz, I., Idorn, T., Rasmussen, S., von Scholten, B. J., Mosenzon, O., & on behalf of the LEADER Trial Investigators (2020) · Clinical Journal of the American Society of Nephrology

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 50

High Blood Pressure 2016: Why Prevention and Control Are Urgent and Important. The World Hypertension League, International Society of Hypertension, World Stroke Organization, International Diabetes Foundation, International Council of Cardiovascular Prevention and Rehabilitation, International Society of Nephrology

Campbell, N. R., Khalsa, T., Executive:, W. H. L., Lackland, D. T., Niebylski, M. L., Nilsson, P. M., Redburn, K. A., Orias, M., Zhang, X., International Society of Hypertension Executive:, et al. (2016) · The Journal of Clinical Hypertension

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 40

Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis

Plutzky, J., Garber, A., Falahati, A., Toft, A. D., & Poulter, N. R. (2009) · Canadian Journal of Diabetes

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 33

Blood pressure measurement in special populations and circumstances

Stergiou, G. S., Dolan, E., Kollias, A., Poulter, N. R., Shennan, A., Staessen, J. A., Zhang, Z., & Weber, M. A. (2018) · The Journal of Clinical Hypertension

Blood Pressure and Hypertension StudiesNon-Invasive Vital Sign Monitoring

Cited by 29

Are the American Heart Association/American College of Cardiology High Blood Pressure Guidelines Fit for Global Purpose?: Thoughts From the International Society of Hypertension

Poulter, N. R., Castillo, R., Charchar, F. J., Schlaich, M. P., Schutte, A. E., Tomaszewski, M., Touyz, R. M., & Wang, J.-G. (2018) · Hypertension

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 23